Capgemini Releases New Study on Financial Impact of Masimo Noninvasive and Continuous Hemoglobin ... ( Hospital-wide Implementation of Masim...)

Capgemini Releases New Study on Financial Impact of Masimo Noninvasive and Continuous Hemoglobin (SpHb(TM))

Date:4/16/2009

Hospital-wide Implementation of Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) Could Generate Nearly $500,000 in Net Annual Cost Savings and Financial Gains

IRVINE, Calif., April 16, Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that Capgemini, a leading supplier of global consulting and technology services, has released a study showing that a typical 500 bed hospital incorporating Masimo Rainbow SET Pulse CO-Oximetry into its clinical standards and care pathways could generate nearly $500,000 in net annual cost savings and financial gains.

Capgemini reported that significant financial benefits could be derived from incorporating noninvasive total hemoglobin (SpHb) by helping clinicians prevent unnecessary blood transfusions, identify internal bleeding earlier, and increase patient throughput. The study concluded that "whether considered on a per-patient, department, or hospital-wide analysis, there are significant clinical and financial benefits to implementing Pulse CO-Oximetry technology."

Masimo commissioned the Capgemini study for a third-party evaluation of the potential financial benefits of Masimo Rainbow SET. Hospital inputs were evaluated by Capgemini through 70 in-depth one-on-one interviews with clinicians and other decision-makers at 15 U.S. acute care hospitals and then quantified through a follow-on survey of 200 hospital-based physicians. The study found that the majority of anesthesiologists and two-thirds of surgeons believed that SpHb monitoring could prevent at least one unnecessary blood transfusion in every ten surgical cases on which it was used, contributing to $93,600 in net annual cost savings in a surgical department using 20 SpHb-enabled devices. The study also found that the majority of int
'/>"/>

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. Glenwood Systems, LLC Releases EMR Practice Management and Medical Billing Process Improvement Program
2. Sentillion Releases Healthcare Do It Yourself Tool for Single Sign-On and Context Management Application Interfaces
3. Illinois Lottery Releases New MS Ticket, Dash! For Cash
4. U.S. Department of Health & Human Services Releases Public Service Announcements to Encourage Healthy Lifestyles
5. NIH releases the first research plan to reduce the burden of digestive diseases
6. APHA Releases Agenda for Health Reform
7. Pennsylvania Patient Safety Authority Releases March Advisory
8. Consumer Group Releases New Study About Defective Heart Devices and Implants; Patients Arrive in DC Tomorrow
9. Providence Service Corporation Releases Fourth Quarter and Audited Year End 2008 Results
10. HCLA Releases Report on Status of Medical Liability Reform
11. MayoClinic.com Releases New Design

Post Your Comments:

Capgemini Releases New Study on Financial Impact of Masimo Noninvasive and Continuous Hemoglobin ...( Hospital-wide Implementation of Masim...),Health